L-Asparaginase (ASNase) is important for the treatment of childhood acute lymphoblastic leukemia. ASNase sensitivity has been shown to correlate with the asparagine synthetase (ASNS) protein content in acute lymphoblastic leukemia cell lines. However, there have been few studies to determine ASNS protein levels in human leukemias, since no appropriate monoclonal antibody is available for such quantitative analysis. In this study, we report the generation of anti-ASNS monoclonal antibodies, which are applicable to flow cytometry and enzyme-linked immunosorbent assay. These monoclonal antibodies should provide a valuable tool for the quantification of ASNS protein level and estimation of ASNase-resistance in leukemia cells.
Get full access to this article
View all access options for this article.
References
1.
RichardsNGJ, KilbergMS. Asparagine synthetase chemotherapy. Annu Rev Biochem, 2006; 75:629–654.
2.
KiriyamaY, KubotaM, TakimotoT, KitohT, TanizawaA, AkiyamaY, MikawaH. Biochemical characterization of U937 cells resistant to L-asparaginase: the role of asparagine synthetase. Leukemia, 1989; 3:294–297.
3.
AghaiypourK, WlodawerA, LubkowskiJ. Structural basis for the activity and substrate specificity of Erwinia chrysanthemi L-asparaginase. Biochemistry, 2001; 40:5655–5664.
4.
UenoT, OhtawaK, MitsuiK, KoderaY, HirotoM, MatsushimaA, InadaY, NishimuraH. Cell cycle arrest and apoptosis of leukemia cells induced by L-asparaginase. Leukemia, 1997; 11:1858–1861.
5.
AslanianAM, FletcherBS, KilbergMS. Asparagine synthetase expression alone is sufficient to induce l-asparaginase resistance in MOLT-4 human leukaemia cells. Biochem J, 2001; 357:321–328.
6.
ScherfU, RossDT, WalthamM, SmithLH, LeeJK, TanabeL, KohnKW, ReinholdWC, MyersTG, AndrewsDT, ScudieroDA, EisenMB, SausvilleEA, PommierY, BotsteinD, BrownPO, WeinsteinJN. A gene expression database for the molecular pharmacology of cancer. Nat Genet, 2000; 24:236–244.
7.
LorenziPL, LlamasJ, GunsiorM, OzbunL, ReinholdWC, VarmaS, JiH, KimH, HutchinsonAA, KohnEC, GoldsmithPK, BirrerMJ, WeinsteinJN. Asparagine synthetase is a predictive biomarker of L-asparaginase activity in ovarian cancer cell lines. Mol Cancer Ther, 2008; 7:3123–3128.
8.
HutsonRG, KitohT, Moraga AmadorDA, CosicS, SchusterSM, KilbergMS. Amino acid control of asparagine synthetase: relation to asparaginase resistance in human leukemia cells. Am J Physiol, 1997; 272:C1691–1699.
9.
LeslieM, CaseMC, HallAG, CoulthardSA. Expression levels of asparagine synthetase in blasts from children and adults with acute lymphoblastic leukemia. Br J Haematol, 2006; 132:740–742.
10.
StamsWA, den BoerML, BeverlooHB, van WeringER, PietersR. Upregulation of asparagine synthetase and cell cycle arrest in t(12;21)-positive ALL. Leukemia, 2005; 19:318–319.
AbbatielloSE, PanYX, ZhouM, WayneAS, VeenstraTD, HungerSP, KilbergMS, EylerJR, RichardsNGJ, ConradsTP. Mass spectrometric quantification of asparagine synthetase in circulating leukemia cells from acute lymphoblastic leukemia patients. J Proteomics, 2008; 71:61–70.
13.
SuN, PanYX, ZhouM, HarveyRC, HungerSP, KilbergMS. Correlation between asparaginase sensitivity and asparagine synthetase protein content, but not mRNA, in acute lymphoblastic leukemia cell lines. Pediatr Blood Cancer, 2008; 50:274–279.
14.
CiusteaM, GutierrezJA, AbbatielloSE, EylerJR, RichardsNGJ. Efficient expression, purification, and characterization of C-terminally tagged, recombinant human asparagine synthetase. Arch Biochem Biophys, 2005; 440:18–27.
15.
LindleyKM, SuJL, HodgesPK, WiselyGB, BledsoeRK, CondreayJP, WinegarDA, HutchinsJT, KostTA. Production of monoclonal antibodies using recombinant baculovirus displaying gp64-fusion proteins. J Immunol Methods, 2000; 234:123–135.
16.
TanakaT, TakenoT, WatanabeY, UchiyamaY, MurakamiT, YamashitaH, SuzukiA, AoiR, IwanariH, JiangSY, NaitoM, TachibanaK, DoiT, ShulmanAI, MangelsdorfDJ, ReiterR, AuwerxJ, HamakuboT, KodamaT. The generation of monoclonal antibodies against human peroxisome proliferator-activated receptors (PPARs)J Atheroscler Thromb, 2002; 9:233–242.
17.
SaitohR, OhtomoT, YamadaY, KamadaN, NezuJ, KimuraN, FunahashiS, FurugakiK, YoshinoT, KawaseY, KatoA, UedaO, JishageK, SuzukiM, FukudaR, AraiM, IwanariH, TakahashiK, SakihamaT, OhizumiI, KodamaT, TsuchiyaM, HamakuboT. Viral envelope protein gp64 transgenic mouse facilitates the generation of monoclonal antibodies against exogenous membrane proteins displayed on baculovirus. J Immunol Methods, 2007; 322:104–117.
IrinoT, KitohT, KoamiK, KashimaT, MukaiK, TakeuchiE, HongoT, NakahataT, SchusterSM, OsakaM. Establishment of real-time polymerase chain reaction method for quantitative analysis of asparagine synthetase expression. J Mol Diagn, 2004; 6:217–224.
20.
StamsWA, den BoerML, HollemanA, AppelIM, BeverlooHB, van WeringER, Janka-SchaubGE, EvansWE, PietersR. Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia. Blood, 2005; 105:4223–4325.
21.
StamsWA, den BoerML, BeverlooHB, MeijerinkJP, StigterRL, van WeringER, Janka-SchaubGE, SlaterR, PietersR. Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL. Blood, 2003; 101:2743–2747.
22.
IwamotoS, MiharaK, DowningJR, PuiCH, CampanaD. Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase. J Clin Invest, 2007; 117:1049–1057.
23.
WilliamsDA. A new mechanism of leukemia drug resistance?N Engl J Med, 2007; 357:77–78.
